Advanced Medical Specialties
Oncology
Dr. Michael B. Troner, MD
Michael B. Troner, MD works in the field of Oncology. He studied medicine at State University of New York Downstate Medical Center College of Medicine. He received 10 awards: "America's Top Doctors", "America's Top Doctors for Cancer", "Top Doctors:South Florida", "Fellow (FASCO)", "SouthFloridaCEO: Top Doctors", "Miami Metro City Guide: Top Doctors", "Top Doctors: Florida", "Fellow (FACP)", "Super Doctor" and "Top MD". Michael B. Troner, MD is a published physician as well. He has 13 publications published. The latest was: Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy. He is registered with Medicare and accepts Medicare payments.
Publications
- Radiation technique influence on percutaneous endoscopic gastrostomy tube dependence: Comparison between two radiation schemes.
- Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head a...
- Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and n...
- Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or ...
- Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.
- Successful rechallenge with etoposide phosphate after an acute hypersensitivity reaction to etoposide.
- Phase II evaluation of weekly cisplatin in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group Trial.
- Advanced adenocarcinoma of the kidney: therapy with lomustine, vinblastine, hydroxyurea, and medroxyprogesterone acetate and regression analysis of factors relating to...
- Aminoglutethimide in the treatment of metastatic breast cancer.
- Cyclophosphamide, doxorubicin, and cisplatin (CAP) in the treatment of urothelial malignancy: a pilot study of the Southeastern Cancer Study Group.
- Aminoglutethimide in the management of metastatic breast cancer.
- Phase II study of mitomycin C and vinblastine in women with advanced breast cancer refractory to standard cytotoxic therapy.
Schools
SUNY Downstate Medical Center College Of Medicine
University Of Maryland Medical System Baltimore
University Of Miami School Of Medicine
Procedures Preformed
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
- Top Doctors:South Florida
- Fellow (FASCO)
- SouthFloridaCEO: Top Doctors
- Miami Metro City Guide: Top Doctors
- Top Doctors: Florida
- Fellow (FACP)
- Super Doctor
- Top MD
Education
-
Jackson Memorial Hospital - Jackson Health System
-
University of Maryland
-
State University of New York Downstate Medical Center College of Medicine
Hospital
-
Baptist Hospital of Miami
Drug Facts
| NPI NUMBER |
|
1336136522 |
| NPPES Provider LastName |
|
TRONER |
| NPPES Provider FirstName |
|
MICHAEL |
| NPPES Provider ZIPCode |
|
331762148 |
| NPPES Provider State |
|
FL |
| Specialty Description |
|
Medical Oncology |
| Total Claim Count |
|
1218.0 |
| Distinct Opioid Count |
|
4.0 |
| Opioid Claim Count |
|
77.0 |
| Percent Opioid Claims |
|
6.32 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
| National Provider Identifier [NPI] |
1336136522 |
| Last Name Of The Provider |
TRONER |
| First Name Of The Provider |
MICHAEL |
| View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog
This Doctor is OpenDoctor Recommended.
This doctor has more publications
